Birmingham, West Midlands -- (SBWIRE) -- 01/23/2014 -- Value Penny Stocks issues special report on DARA Biosciences Inc (NASDAQ:DARA), News Corp (NASDAQ:NWSA), Polycom Inc (NASDAQ:PLCM), Idenix Pharmaceuticals Inc (NASDAQ:IDIX).
DARA Biosciences Inc (NASDAQ:DARA) ended its recent business day with the gain of 21.64% and closed at the price of $0.870 after opening at $0.74. The stock traded during its last trading session with the total volume of 3,206,857 shares, as compared to its average volume of 1.68 million shares. DARA BioSciences, Inc., a development stage biopharmaceutical company, develops and commercializes oncology treatment and supportive care pharmaceutical products in the United States.
Will DARA Continue To Move Higher? Find Out Here
News Corp (NASDAQ:NWSA) remained among the day decliners and traded with volume of 3,109,910 shares in the last session, as compared to average volume of 3.02 million shares. In comparison with 52 week range of $14.39 - $18.17, it faced lowest price of $16.56 during the last trading session whereas its day highest price was $16.99. The company’s total market capitalization is $9.64 billion, along with 578.85 million shares outstanding. News Corporation, a media and information services company, focuses on creating and distributing authoritative and engaging content to consumers and businesses worldwide.
Has NWSA Found The Bottom And Ready To Gain Momentum? Find Out Here
Polycom Inc (NASDAQ:PLCM) showed 3,074,371 shares in volume during the last trading session, while the average trading volume remained 1.88 million shares. The stock kicked off its trading session at $11.89 and closed at $11.77 after declining -0.93%. Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration. The company offers video, voice, and content-management and content-sharing solutions, such as telepresence and conference room systems, home/work office solutions, applications for mobile devices, browser-based video collaboration, cloud-delivered services, and specialized healthcare video carts.
Why Should Investors Buy PLCM After the Recent Fall? Just Go Here and Find Out
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock traded during its last trading session with the total traded volume of 3,037,219 shares versus its average volume of 1.32 million shares. The company opened its trade at the price of $8.01 and its closing price was $7.99 after losing -0.25% for the day. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV).
Will IDIX Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)